Efficient Training and Deployment Of Generative AI and Large Language Models (LLMs) For Accelerating Drug Discovery
Life sciences is one of the most vibrant sectors in the modern economy. It sits at the nexus of medicine and digital technology, collecting and utilizing biological data in innovative ways using modern technologies to solve decades-old problems. Now, it’s turning to artificial intelligence (AI) to solve the biggest of all: getting new medicines to market more quickly.
This whitepaper details the challenges involved in the long, expensive road to drug discovery and the multiple stages and processes it entails. It goes on to map how the use of AI technologies including deep learning (DL) and natural language processing (NLP) are driving change, particularly when it comes to the collection, analysis and formulation of vast biomedical data sets from multiple sources.